Acute Ischemic Stroke Therapeutics Market: Growth Opportunities Led by Athersys Inc. and Bayer AG - Technavio

Acute Ischemic Stroke Therapeutics Market: Growth Opportunities Led by Athersys Inc. and Bayer AG – Technavio

NEW YORK, November 28, 2022 /PRNewswire/ — The acute ischemic stroke (AIS) therapeutics market size is estimated to increase by $1,524.49 million from 2022 to 2027, to a CAGR of 5.72%. Market growth will be driven by the growing prevalence of high-risk factors. Additionally, the use of technologies such as TBI is expected to drive the growth of the market.

Technavio has announced its latest market research report titled Global Acute Ischemic Stroke Therapeutics Market 2023-2027

Technavio has announced its latest market research report titled Global Acute Ischemic Stroke Therapeutics Market 2023-2027

The report extensively covers the Acute Ischemic Stroke (AIS) Therapeutics Market Segmentation By Type (Thrombolytic, Anticoagulant, Antiplatelet, and Antihypertensive), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and geography (North America, Europe, Asiaand Rest of the World (ROW). Request a free sample report

Acute Ischemic Stroke Therapeutics Market – Suppliers

The global AIS therapies market is a fragmented market, with the presence of various large and small players. Major players are focusing on market consolidation through strategic alliances and increased acquisitions to increase their market shares. In addition, these providers are continually innovating their offerings. Some of the major providers are listed below:

  • Athersys Inc.

  • Bayer AG

  • Biogene Inc.

  • Boehringer Ingelheim International GmbH

  • Medtronic AG

  • NoNO Inc.

  • SanBio Co. Ltd.

  • Stryker Corp.

  • Amgen Inc.

  • Astra Zeneca Plc

  • Bristol Myers Squibb Co.

  • Daiichi Sankyo Co.Ltd.

  • F. Hoffmann La Roche Ltd.

  • Johnson & Johnson

  • Merck & Co. Inc.

  • Sanofi SA

  • Teva Pharmaceutical Industries Ltd.

Product information and news

• athersys.com: The company offers treatments for acute ischemic strokes such as Repatha.

bayer.com – The company offers therapies for acute ischemic stroke such as BRILINTA ticagrelor tablets.

biogen.com – The company offers therapeutics for acute ischemic stroke such as Master 2 MultiStem cell therapy.

For detailed information on vendor product offerings and growth strategies, buy the report.

Acute Ischemic Stroke Therapeutics Market – Geographic Landscape

North America is estimated to represent 38% of market growth over the forecast period. Market growth in this region is attributed to factors such as expected approval of late-stage pipeline molecules including BIIB093 (intravenous glibenclamide), BRILINTA, MultiStem, and NA-1. Additionally, the region is expected to see the availability of various diagnostics and drugs for the treatment of stroke, which will drive the growth of the market.

Acute Ischemic Stroke Therapeutics Market – Market Segmentation

The thrombolytics segment is estimated to contribute the largest share of the global market growth during the forecast period. One of the factors driving the growth of this segment is the availability of US FDA approved therapeutic treatments for AIS. For example, the IV drug alteplase is sold under the brand name Activase. It is a tissue plasminogen activator and is used for multiple indications such as AIS, acute myocardial infarction (AMI) and acute massive pulmonary embolism (PE). Download a free sample report

What are the key data covered in this Acute Ischemic Stroke (AIS) Therapeutics Market report?

  • CAGR of the market over the forecast period

  • In-depth insights into the factors that will drive the Acute Ischemic Stroke (AIS) Therapeutics Market growth between 2023 and 2027

  • Accurate estimation of the size of the Acute Ischemic Stroke (AIS) Therapeutics market and its contribution to the parent market

  • Accurate predictions on upcoming trends and changes in consumer behavior

  • Acute Ischemic Stroke (AIS) Therapeutic Treatments Market Growth in APAC, North America, Europe, Middle East and Africaand South America

  • In-depth analysis of the market competitive landscape and detailed vendor information

  • Comprehensive analysis of factors that will challenge the growth of the Acute Ischemic Stroke (AIS) Treatments Market vendors

Technavio’s library includes over 17,000 reports, covering over 2,000 emerging technologies. Subscribe to our “Basic Plan” right now $5,000 and get lifetime access to Technavio Insights

Related reports:

Acute Myeloid Leukemia (AML) Treatment Market APAC by type and geography – Forecast and analysis 2022-2026: APAC Acute Myeloid Leukemia (AML) Treatment Market Size is Expected to Grow by $277.03 million from 2021 to 2026, and the growth momentum of the market will accelerate at a CAGR of 12.83%.

Alzheimer’s disease therapeutics market by Drug Class and Geography – Forecast and Analysis 2022-2026: The Alzheimer’s disease treatment market size is expected to grow by $3.99 billion from 2021 to 2026, and the growth momentum of the market will accelerate at a CAGR of 8.76%.

Scope of Acute Ischemic Stroke Therapeutics Market

Report cover

Details

Page number

120

base year

2022

Historical period

2017-2021

Forecast period

2023-2027

Growth momentum and CAGR

Accelerate at a CAGR of 5.72%

Market Growth 2023-2027

$1524.49 million

Market structure

Fragmented

Annual growth (%)

5.49

Regional analysis

North America, Europe, Asia and Rest of the World (ROW)

Successful market contribution

North America at 38%

Main consumer countries

USA, Canada, UK, Germany and China

Competitive landscape

Leading companies, positioning of vendors in the market, competitive strategies and industry risks

Profiled companies

Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Medtronic Plc, NoNO Inc., SanBio Co Ltd., Stryker Corp., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd . ., F. Hoffmann La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Sanofi SA and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis; Market Growth Drivers and Barriers; Analysis of fast growing and slow growing segments for the forecast period

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Search Technavio “Health care“Research Reports

Contents

1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Type

6 Market Segmentation by Distribution Channel

7 Customer Landscape

8 Geographic landscape

9 drivers, challenges and trends

10 Supplier Landscape

11 Vendor Analysis

12 Appendix

About Technavio

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

contacts

Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: media@technavio.com
Website: www.technavio.com/

Global Acute Ischemic Stroke Therapy Market 2023-2027

Global Acute Ischemic Stroke Therapy Market 2023-2027

Quote

Quote

View original content to download multimedia: https://www.prnewswire.com/news-releases/acute-ischemic-stroke-therapeutics-market-growth-opportunities-led-by-athersys-inc-and-bayer-ag —technavio-301687079.html

SOURCETechnavio

#Acute #Ischemic #Stroke #Therapeutics #Market #Growth #Opportunities #Led #Athersys #Bayer #Technavio

Leave a Comment

Your email address will not be published. Required fields are marked *